Between 2022 and 2023, reported measles cases rose 79% worldwide. WHO and CDC published a joint report documenting the surge: 10.3 million estimated cases and 107,500 estimated deaths in 2023 alone, the vast majority in children under 5. In 2024, the trajectory worsened. An estimated 37 million children missed at least one dose of measles vaccine between 2021 and 2023, creating immunity gaps that the virus is now exploiting with ruthless efficiency.
Why is measles surging now?
Global coverage of the first measles vaccine dose (MCV1) dropped to 83% in 2022, the lowest level since 2008, and recovered only marginally to 84% in 2023. Second-dose coverage (MCV2) sat at just 74%. Measles requires 95% population immunity to prevent sustained transmission because of its extreme contagiousness, with an R0 of 12-18. For every percentage point below that threshold, the virus finds new hosts.
COVID-19 disrupted routine immunization programs worldwide. Clinic closures, supply chain interruptions, and overwhelmed health systems diverted resources away from childhood vaccination campaigns in 2020 and 2021. Recovery has been slow. UNICEF reported that 14.5 million children received no vaccines at all ("zero-dose children") in 2023, a population concentrated in conflict zones, remote regions, and urban informal settlements.
Vaccine hesitancy has compounded the problem in high-income countries. Misinformation linking the MMR vaccine to autism, debunked thoroughly by dozens of studies involving millions of children, continues to circulate on social media platforms. Philosophical and religious exemption rates have climbed in several US states. Idaho, for example, had kindergarten MMR coverage of just 79% in the 2023-24 school year.
Where are the worst outbreaks?
Yemen, Ethiopia, the DRC, and Pakistan have borne the heaviest burden, each reporting tens of thousands of cases since 2023. Conflict and displacement are common threads. In Yemen, where civil war has shattered the healthcare system, measles circulates continuously with periodic explosive outbreaks in displacement camps.
High-income countries aren't immune. The United States recorded over 900 measles cases in 2024, the highest annual total since 1994. Outbreaks clustered in communities with low vaccination rates: parts of Ohio, Florida, and Washington state. A single imported case in an under-vaccinated community can trigger chains of 10-20 infections within weeks because of how efficiently measles spreads through respiratory aerosols that linger in the air for up to two hours after an infectious person leaves the room.
Europe saw a dramatic surge in 2023-2024, with WHO's European Region reporting over 300,000 cases across the two-year period. Romania, Kazakhstan, and Russia accounted for the largest share. The UK, which had achieved measles elimination status, lost it in 2024 after sustained outbreaks in London and Birmingham linked to declining MMR uptake among children born during the pandemic years.
Why does measles matter beyond measles?
Epidemiologists call measles the "canary in the coal mine" for immunization systems. Because of its extreme transmissibility, measles is always the first vaccine-preventable disease to resurge when coverage drops. An outbreak signals that the immunization infrastructure has a gap, and that gap affects every other vaccine-preventable disease too.
Research published in Science in 2019 revealed something even more troubling: "immune amnesia." Measles infection destroys 11-73% of a patient's existing antibody repertoire, effectively wiping out immune memory built from previous infections and vaccinations. A child who recovers from measles becomes newly vulnerable to diseases they were previously protected against. That immunological reset takes 2-3 years to rebuild through natural re-exposure.
Measles is also a proxy for healthcare system reach. Countries that deliver two doses of measles vaccine to 95%+ of children are almost certainly delivering other essential health services too. When measles coverage falls, it indicates problems far beyond a single disease.
What does this mean for you?
Check your vaccination records. If you received two doses of MMR vaccine, you have approximately 97% protection against measles and can consider yourself safe. One dose provides about 93% protection. No dose leaves you fully susceptible to a virus so contagious that 90% of unvaccinated people in a household with an infected person will contract it.
If you're traveling to countries with active outbreaks, confirm your immunity before departure. A blood test (measles IgG titer) can verify whether your vaccine-induced immunity is still intact, which is particularly relevant for people vaccinated before 1989, when the two-dose schedule became standard in the US.
Parents who delayed their children's routine vaccinations during the COVID-19 pandemic should catch up immediately. The CDC's catch-up schedule allows accelerated dosing to close gaps quickly. Your pediatrician can administer the first MMR dose as early as 6 months for infants traveling to outbreak areas, though the standard schedule begins at 12-15 months with a second dose at 4-6 years.
PandemicAlarm rates measles at severity 3/5 in active outbreak regions and 2/5 globally. That rating reflects the disease's high transmissibility and rising case counts balanced against the existence of a highly effective vaccine. The threat is not the virus itself. It's the growing number of people who remain unprotected against it.
Track measles outbreaks on the PandemicAlarm map and review our vaccine supply chain analysis for context on why global immunization coverage has been so slow to recover.